PMID- 35718694
OWN - NLM
STAT- MEDLINE
DCOM- 20231023
LR  - 20231025
IS  - 1878-0938 (Electronic)
IS  - 1553-8389 (Print)
IS  - 1878-0938 (Linking)
VI  - 53S
DP  - 2023 Aug
TI  - A Case of ST Segment Elevation Myocardial Infarction Within 24 h of a Third Dose 
      of COVID-19 mRNA Vaccine.
PG  - S313-S316
LID - S1553-8389(22)00304-9 [pii]
LID - 10.1016/j.carrev.2022.06.012 [doi]
AB  - Although coronavirus disease 2019 (COVID-19) vaccination is known to carry a 
      slight risk of myocarditis and pericarditis, it remains unclear whether it has 
      any impact on coronary artery disease. Here we present a case without particular 
      thrombotic diathesis with a diagnosis of ST segment elevation acute myocardial 
      infarction (STEMI) 19 h after a third dose of a COVID-19 mRNA vaccine. A primary 
      percutaneous coronary intervention procedure for occluded right coronary artery 
      with thrombus aspiration alone was successful in this patient. However, the 
      relationship between STEMI and COVID-19 mRNA vaccination is uncertain, and 
      additional studies to validate thrombogenetic effects of COVID-19 mRNA vaccines 
      are needed. This case was helpful in distinguishing STEMI from myocarditis and 
      pericarditis, which are recognized rare cardiac side effects of COVID-19 
      vaccination. It is important not to hesitate to perform coronary angiography 
      procedures to rule out the possibility of STEMI occurrence, as in this case.
CI  - Copyright (c) 2022 Elsevier Inc. All rights reserved.
FAU - Kawamura, Yota
AU  - Kawamura Y
AD  - Tokai University Hachioji Hospital, Division of Cardiology, Department of 
      Internal Medicine, Hachioji, Japan. Electronic address: youta@f4.dion.ne.jp.
FAU - Yoshimachi, Fuminobu
AU  - Yoshimachi F
AD  - Tokai University Hachioji Hospital, Division of Cardiology, Department of 
      Internal Medicine, Hachioji, Japan.
FAU - Nanao, Tomihisa
AU  - Nanao T
AD  - Tokai University Hachioji Hospital, Division of Cardiology, Department of 
      Internal Medicine, Hachioji, Japan.
FAU - Kasai, Satoshi
AU  - Kasai S
AD  - Tokai University Hachioji Hospital, Division of Cardiology, Department of 
      Internal Medicine, Hachioji, Japan.
FAU - Ikari, Yuji
AU  - Ikari Y
AD  - Tokai University School of Medicine, Division of Cardiology, Department of 
      Internal Medicine, Isehara, Japan.
LA  - eng
PT  - Case Reports
DEP - 20220615
PL  - United States
TA  - Cardiovasc Revasc Med
JT  - Cardiovascular revascularization medicine : including molecular interventions
JID - 101238551
RN  - 0 (COVID-19 Vaccines)
RN  - 0 (mRNA Vaccines)
SB  - IM
MH  - Humans
MH  - Coronary Angiography
MH  - *COVID-19/complications
MH  - *COVID-19 Vaccines/adverse effects
MH  - mRNA Vaccines
MH  - *Myocarditis
MH  - *Percutaneous Coronary Intervention/methods
MH  - *Pericarditis
MH  - *ST Elevation Myocardial Infarction/diagnostic imaging/therapy
MH  - *Thrombosis
MH  - Treatment Outcome
PMC - PMC9197822
OTO - NOTNLM
OT  - Acute myocardial infarction
OT  - COVID-19
OT  - Vaccine
COIS- Declaration of competing interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
EDAT- 2022/06/20 06:00
MHDA- 2023/10/23 12:43
PMCR- 2022/06/15
CRDT- 2022/06/19 22:18
PHST- 2022/05/04 00:00 [received]
PHST- 2022/06/08 00:00 [revised]
PHST- 2022/06/10 00:00 [accepted]
PHST- 2023/10/23 12:43 [medline]
PHST- 2022/06/20 06:00 [pubmed]
PHST- 2022/06/19 22:18 [entrez]
PHST- 2022/06/15 00:00 [pmc-release]
AID - S1553-8389(22)00304-9 [pii]
AID - 10.1016/j.carrev.2022.06.012 [doi]
PST - ppublish
SO  - Cardiovasc Revasc Med. 2023 Aug;53S:S313-S316. doi: 10.1016/j.carrev.2022.06.012. 
      Epub 2022 Jun 15.